Home › Calculator › TXG Dividend Calculator 2026
TXG Dividend DRIP Calculator 2026
5.38% YieldHealthcare10x Genomics, Inc. · NASDAQ
Price: $37.15 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When TXG pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your TXG snowball 📈
$10,000 in TXG → $2.80M in 10 years · $48.17/month
About 10x Genomics, Inc. (TXG) — Dividend Analysis 2026
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
Compare TXG with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full TXG DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open TXG position with:
🌍 TXG Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold TXG.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 5.38% | 2.58% | $538 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 4.57% | 1.77% | $457 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 4.30% | 1.50% | $430 / yr |
| 🇬🇧 UK ISA | 0% | 5.38% | 2.58% | $538 / yr |
| 🇬🇧 UK Taxable | 8.75% | 4.91% | 2.11% | $491 / yr |
| 🇨🇦 TFSA | 0% | 5.38% | 2.58% | $538 / yr |
| 🇨🇦 CA Taxable | 25% | 4.04% | 1.24% | $404 / yr |
| 🇦🇺 Super (pension) | 15% | 4.57% | 1.77% | $457 / yr |
| 🇦🇺 AU Taxable | 30% | 3.77% | 0.97% | $377 / yr |
| 🇩🇪 DE Taxable | 26.375% | 3.96% | 1.16% | $396 / yr |
| 🇫🇷 FR Taxable | 30% | 3.77% | 0.97% | $377 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 TXG Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 TXG Dividend Payment Schedule
TXG pays quarterly — 4 times per year. Next ex-div: TBD.
📊 TXG vs Healthcare Benchmarks
How TXG compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TXG sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ TXG Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-06-22 | 8,527 | $33.29 | $283.9K | ||
| Sale | 2026-06-22 | 9,991 | $34.28 | $342.5K | ||
| Sale | 2026-06-22 | 9,821 | $35.32 | $346.8K | ||
| Sale | 2026-06-22 | 1,661 | $36.16 | $60.1K | ||
| Sale | 2026-06-16 | 5,359 | $32.59 | $174.6K | ||
| Sale | 2026-06-16 | 364 | $33.27 | $12.1K | ||
| A-Award | 2026-06-04 | 8,829 | — | — | ||
| A-Award | 2026-06-04 | 8,829 | — | — | ||
| A-Award | 2026-06-04 | 8,829 | — | — | ||
| A-Award | 2026-06-04 | 8,829 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where TXG earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TXG dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
10x Genomics, Inc. (TXG) is currently trading at $37.15, 81% below its 52-week high. The current dividend yield is 5.38% based on an annual payout of $2.00 per share.
TXG (10x Genomics, Inc.) — 5.38% Dividend Yield Analysis
10x Genomics, Inc. (TXG) is a healthcare stock currently trading at $37.15 with a dividend yield of 5.38%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest TXG News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.